Our research team has developed and studied the MBCR program extensively for the past two decades. The research shows that the MBCR program has a variety health benefits for people living with cancer post-treatment. The benefits of MBCR include better management of stress, mood, the symptoms/side-effects of cancer treatments, better overall physical health, regulation of stress hormones and immune function.

The traditional MBCR program is delivered face-to-face in group setting over a period of 9 weeks. Most of our research has investigated face-to-face MBCR, although we recently developed and successfully tested an online version of the program. Concurrently, we have also developed a mobile app-based versions of the program, which is being investigated in the SEAMLESS Study with people living with cancer post-treatment. 

The Canadian Network for Psychedelic-Assisted Cancer Therapy ('CAN-PACT') is a Canadian national initiative advancing psychedelic-assisted therapy for people with living with cancer, focusing on building a robust evidence base via rigorous research, developing bespoke structured training for healthcare workers, and informing and influencing policy. The program is currently in the preparation stage - building the network, developing studies, protocols, training programs, and exploring regulatory pathways for long-lasting change. In future, the program will be recruiting people living with cancer for clinical trials across various locations in Canada. 

Previous research has found that the gut microbiota play an important role in both mental and physical health. Understanding how chemotherapy affects the gut microbiota and psycho-physiological function has yet to be fully understood. 

 The Chemo-Gut Study is a double-blinded randomized controlled trial investigating the effects of probiotics on gut microbiota, gastrointestinal health, and psychological wellbeing in cancer survivors. 

​